Loading Complete
Heba Mabrouk Mostafa

Heba Mabrouk Mostafa, PhD, MBBCH

Highlights

Languages

  • English

Gender

Female

Johns Hopkins Affiliations:

  • Johns Hopkins School of Medicine Faculty

About Heba Mabrouk Mostafa

Professional Titles

  • Director, Molecular Virology Laboratory, The Johns Hopkins Hospital

Primary Academic Title

Associate Professor of Pathology

Background

Dr. Heba Mostafa completed her M.D. at the Faculty of Medicine, Alexandria University, Egypt.  She then moved to the United States where she earned her Ph.D. in Microbiology at the University of Kansas (Lawrence, KS) followed by three years of Post-Doctoral Research Fellowship at St. Jude Children’s Research Hospital (Memphis, TN).  Dr. Mostafa completed her Clinical Microbiology Fellowship training at the University of Rochester Medical Center (Rochester, NY).  Dr. Mostafa currently serves as an Associate Professor of Pathology at Johns Hopkins school of Medicine and the Director of the Molecular Virology Laboratory at Johns Hopkins Hospital. Dr. Mostafa’s research program focuses on implementing whole genome sequencing in the Molecular Virology Laboratory with applications that include: genomic surveillance of viruses and the correlation between viral evolution and disease severity, understanding the respiratory virome, and developing personalized molecular diagnostic panels for immunocompromised patients.

Research Interests

Genomic surveillance of viruses and the correlation between viral evolution and disease severity. Understanding the respiratory virome and developing personalized molecular diagnostic panels for immunocompromised populations. Implementing innovative molecular diagnostics in the clinical microbiology laboratory

Selected Publications

  • Amary Fall, Raghda E Eldesouki, Jaiprasath Sachithanandham, C Paul Morris, Julie M Norton, David C Gaston, Michael Forman, Omar Abdullah, Nicholas Gallagher, Maggie Li, Nicholas J Swanson, Andrew Pekosz, Eili Y Klein, Heba H Mostafa. The displacement of the SARS-CoV-2 variant Delta with Omicron: An investigation of hospital admissions and upper respiratory viral loads. EBioMedicine. 2022 Apr 20;79:104008. doi: 10.1016/j.ebiom.2022.104008

  • C. Paul Morris, Chun Huai Luo, Jaiprasath Sachithanandham, Maggie Li, Matthew Schwartz, David C Gaston, Victoria Gniazdowski, Nicolas Giraldo-Castillo, Adannaya Amadi, Julie M Norton, William F Wright, Eili Y Klein, Andrew Pekosz and Heba H Mostafa. Large Scale SARS-CoV-2 Molecular Testing and Genomic Surveillance Reveal Prolonged Infections, Protracted RNA shedding, and Viral Reinfections

  • Katharine Uhteg, Adannaya Amadi, Michael Forman, Heba H Mostafa. Circulation of Non- SARS-CoV-2 Respiratory Pathogens and Coinfection with SARS-CoV-2 Amid the COVID-19 Pandemic. Open Forum Infect Dis. 2021 Dec 8;9(3):ofab618. doi: 10.1093/ofid/ofab618

  • Luo CH, Morris CP, Sachithanandham J, Amadi A, Gaston D, Li M, Swanson NJ, Schwartz M, Klein EY, Pekosz A, Mostafa HH. Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Recovery of Infectious Virus Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals. Clin Infect Dis. 2021 Dec 18:ciab986. doi: 10.1093/cid/ciab986. Online ahead of print. PMID: 34922338

  • Morris CP, Luo CH, Amadi A, Schwartz M, Gallagher N, Ray SC, Pekosz A, Mostafa HH. An Update on SARS-CoV-2 Diversity in the United States National Capital Region: Evolution of Novel and Variants of Concern. Clin Infect Dis. 2021 Jul 17:ciab636. doi: 10.1093/cid/ciab636. Online ahead of print. PMID: 34272947

Expertise

Education

University of Kansas

Graduate School, PhD, 2014

Board Certifications

Medical Microbiology

American Board of Medical Microbiology, 2019